perinatal depression

Focus on preventing perinatal depression

The evidence from clinical trials is strong: we have the tools to prevent depression, says clinical psychologist Ricardo Muñoz. We also have the perfect place to start: with expectant or new mothers. It’s a time when many women are at risk, interventions could be wrapped up with existing prenatal care to reduce any stigma, and mothers’ good mental health will benefit their own children as well.

Nature | 11 min read

The Fifth Dimension

The Fifth Dimension Visualizing beyond the edge of the universe and the place of non-space Ella Alderson in Predict6 min read

Fecal Transplant

Fecal Transplant Death Mystery Solved Two people became ill after a poop transplant, and one of them died. Experts explain what went wrong and why… Dana G Smith in Elemental6 min read

Carlos Drumond de Andrade

Carlos Drummond de Andrade – Wikipédia, a enciclopédia livre

Prontosil Rubrum

Outros nomes p-sulfamidocrisoidina 4-((2,4-diaminofenil) azo)benzenosulfonamida Identificadores Número CAS 103-12-8, 33445-35-1 (cloridrato) PubChem 66895 Propriedades Fórmula molecular C12H13N5O2S C12H13N5O2S•HCl (cloridrato) Ponto de fusão 248-250 °C (cloridrato) [1] Solubilidade em água Cloridrato: 1 g em 400 mL de água (aumenta significantemente em temperaturas elevadas). Solúvel também em etanol, acetona, gorduras e óleos.[1]

1895: German bacteriologist and pathologist Gerhard Domagk, recipient of the 1939 Nobel Prize for Physiology or Medicine for his discovery (announced in 1932) of the antibacterial effects of Prontosil, was born. Prontosil, also called sulfamidochrysoidine, trade name of the first synthetic drug used in the treatment of general bacterial infections in humans. Prontosil was introduced into medicine in the 1930s. Prontosil resulted from research, directed by German chemist and pathologist Gerhard Domagk, on the antibacterial action of azo dyes. A red azo dye of low toxicity, Prontosil was shown by Domagk to prevent mortality in mice infected with Streptococcus bacteria. The dye was also effective in controlling Staphylococcus infections in rabbits. Within a relatively short period, it was demonstrated that Prontosil was effective not only in combating experimental infections in animals but also against streptococcal diseases in humans, including meningitis and puerperal sepsis. Later it was found that Prontosil is disrupted in the tissues to form para-aminobenzenesulfonamide (sulfanilamide). Prontosil has been replaced in clinical use by newer sulfonamide drugs, including sulfanilamide, sulfathiazole, sulfamethoxazole, and others. LEARN MORE in these related Britannica articles: history of medicine: Sulfonamide drugs … announced that the red dye Prontosil is active against streptococcal infections in mice and humans. Soon afterward French workers showed that its active antibacterial agent is sulfanilamide. In 1936 English physician Leonard Colebrook and colleagues provided overwhelming evidence of the efficacy of both Prontosil and sulfanilamide in streptococcal septicemia (bloodstream… pharmaceutical industry: Early efforts in the development of anti-infective drugs …of the dyes, known as Prontosil, was later found to be metabolized in the patient to sulfanilamide, which was the active antibacterial molecule. In 1933 Prontosil was given to the first patient, an infant with a systemic staphylococcal infection. The infant underwent a dramatic cure. In subsequent years many derivatives… chemotherapy The discovery of Prontosil in the early 1930s proved that antibacterial agents could be developed. Prontosil was the forerunner of the sulfonamide drugs, which came to be widely used for the treatment of bacterial infections in humans and domestic animals.…

RS Saúde Pública

No Centro Histórico da Santa Casa

12 de novembro – às 19hs

Time-lapse

20 vídeos time-lapse incríveis que você precisa ver

SUPER LISTAS

20 vídeos time-lapse incríveis que você precisa ver

Por Natasha Romanzot

Universe 5%

“It is just embarrassing to live in a Universe where you only know 5% of it.”

Cosmologist Ofer Lahav welcomes the first observations by the Dark Energy Spectroscopic Instrument (DESI). The telescope will conduct the largest spectroscopic survey of galaxies ever to try to uncover the nature of dark energy. (BBC)
Read more: Dark-energy mapper will reconstruct 11 billion years of cosmic history (Nature, from August)